84 related articles for article (PubMed ID: 21323803)
1. Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders.
Nurden P; Youlouz-Marfak I; Siberchicot F; Kostrzewa E; Andia I; Anitua E; Nurden AT
Haemophilia; 2011 Jul; 17(4):620-4. PubMed ID: 21323803
[TBL] [Abstract][Full Text] [Related]
2. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
Gupta PK; Charan VD; Saxena R
Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
Morimoto Y; Yoshioka A; Sugimoto M; Imai Y; Kirita T
Oral Dis; 2005 Jul; 11(4):243-8. PubMed ID: 15984956
[TBL] [Abstract][Full Text] [Related]
8. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
10. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions.
Devecioğlu O; Unüvar A; Anak S; Bilge I; Ander H; Ziylan O
Turk J Pediatr; 2003; 45(1):64-6. PubMed ID: 12718376
[TBL] [Abstract][Full Text] [Related]
11. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.
Marcus PD; Nire KG; Grooms L; Klima J; O'Brien SH
Haemophilia; 2011 Mar; 17(2):223-7. PubMed ID: 20860605
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of inherited bleeding disorders in pediatrics.
El-Bostany EA; Omer N; Salama EE; El-Ghoroury EA; Al-Jaouni SK
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):771-5. PubMed ID: 19002043
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
[TBL] [Abstract][Full Text] [Related]
14. [Management of patients with Type 2B von Willebrand's disease during delivery and puerperium].
Güth U; Tsakiris DA; Reber A; Holzgreve W; Hösli I
Z Geburtshilfe Neonatol; 2002; 206(4):151-5. PubMed ID: 12198592
[TBL] [Abstract][Full Text] [Related]
15. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Asatiani E; Kessler CM;
Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and management of type 1 von Willebrand disease.
Castaman G; Rodeghiero F
Expert Rev Hematol; 2011 Feb; 4(1):95-106. PubMed ID: 21322782
[TBL] [Abstract][Full Text] [Related]
19. Treatment of von Willebrand's disease.
Mannucci PM
J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
[TBL] [Abstract][Full Text] [Related]
20. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
